Clinical Trial Update: Bone Marker Assessment of Multiple Myeloma Patients Treated With Aminobisphosphonates [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update assessing bone marker responses in multiple myeloma patients treated with aminobisphosphonates; results have been posted after com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• aminobisphosphonates

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2017-03-10